A Phase II Study of Anlotinib in MTC Patients
Clinical trial NCT01874873 · COMPLETED
Trial details
- NCT number
- NCT01874873
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2016-12-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.